Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 16.7B | 12.6B | 10.8B | 11.8B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 924.1M | 275.8M | 450.0M | 1.1B |
Other operating expenses | 733.9M | 584M | -781.3M | -3.6B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | 460.7M | — |
Expense | — | — | 137.1M | — |
Other income expense | 0 | 0 | -400K | -1.6M |
Pretax income | 2.1B | 132.4M | -188.2M | 1.6B |
Tax provision | 0 | 0 | 0 | 0 |
Net income | 2.1B | 132.4M | -188.2M | 1.6B |
Basic EPS | — | 0.1 | -0.1 | — |
Diluted EPS | — | 0.1 | -0.1 | — |
Basic average shares | — | 1.9B | 1.8B | — |
Diluted average shares | — | 1.9B | 1.8B | — |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |